In Brief: Cholestech/Metra Biosystems
This article was originally published in The Gray Sheet
Executive Summary
Cholestech/Metra Biosystems: Sign agreement to develop and market a cassette for the Cholestech L-D-X point-of-care diagnostic system to assess bone resorption. The new cassette will utilize Metra's Pyrilinks-D urine assay, which was cleared by FDA in December 1995 ("The Gray Sheet" Jan. 25, 1996, In Brief). Under the agreement, Cholestech will market the test through its existing distribution channels in the U.S., while the firms will work together to market and distribute the tests internationally. The agreement also provides for the development of cassettes for additional Metra assays that would be added on to the Cholestech system. Metra made "a small equity investment" in Cholestech and will make additional investments "based upon the achievement of certain product development milestones," Cholestech says...